At J+D we work alongside Pharmaceutical Forecasters, Analysts, Business Insights Managers and Marketing Departments to develop models that cater to the unique needs of individuals and pharmaceutical companies alike.
Our approach strikes a balance between navigating the intricacies of the market and providing user-friendly, innovative technology, all while adhering to the highest standards of pharmaceutical forecasting principles.
With extensive experience within the pharma industry, our team understand the complex challenges within both global and local forecasting, allowing us to apply these to our solutions.
Driven by our knowledge, experience and passion for innovation, we aim to inspire confidence in pharmaceutical investment decisions allowing us to shape the market alongside our valued clients.
When you choose us as your partner, you can trust us to deliver results that exceed your expectations, driven by our shared values.
Our collaborative approach extends beyond our internal teams; we actively seek partnerships with customers, suppliers, and industry leaders to create mutually beneficial outcomes.
Excellence is not just a goal; it’s a standard we uphold in everything we do. We continuously raise the bar, challenging ourselves to deliver exceptional quality and exceed expectations.
Transparency and clear communication are at the core of how we operate. We believe that with this approach, we can make informed decisions and deliver exceptional results.
We embrace change and disruption, seeking new ways to bring ideas to life. Our team is encouraged to think creatively and fearlessly, driving innovation across all aspects of our business.
We have solutions designed to cater to any therapy area or classes, including oncology, rare diseases and epidemiology, providing specialized forecasting models and tools that are tailored to the unique characteristics of each therapy area.
We have delivered thousands of forecasting models and solutions across more than 70 countries, covering multiple therapy areas from the niche to the more common.
Identifying the lack of specialist forecasting capability within the pharmaceutical industry sparked the inception of J+D Forecasting.
Since the beginning, we’ve been dedicated to providing solutions to the challenges faced by forecasting teams, focusing solely on delivering best practice models, innovative forecasting solutions and expert support to the industry.
As the market evolved, so did we. We listened to our clients’ needs and developed our FC+ suite of software, enabling them to quickly build sophisticated Excel models with ease and accuracy. When clients sought process efficiencies through cloud-based solutions, we responded with FC365—the most forecast-friendly platform in the pharmaceutical industry.
Led by our co-founder David James and supported by long-standing technical and consultant teams, we continue to evolve, leveraging innovative technology to drive process efficiencies for our clients. Today, J+D Forecasting, an Evaluate company, stands as one of the leading providers of pharmaceutical forecasting solutions, supporting forecasting for some of the largest brands in the market.
Jan 2011, J&D Consulting was created with the aim of bringing better forecasting to the pharmaceutical industry.
Our success is built from our consultancy roots, building bespoke Excel models for top 20 pharma, to introduce transparency and consistency.
Our first syndicated software release to allow forecasters to build unlimited best practice models independently.
Rebrand to become J+D Forecasting, identifying us as more than a consulting provider, with a comprehensive range of solutions in our toolkit.
Developed for our clients, this unique knowledge centre and training hub gave easy access to our forecasting tools and experts insights.
Following the success of our face-to-face training workshops, we digitalised the format to offer clients the first online pharmaceutical forecasting training course of its kind.
This exciting evolution of our Teams app to a cloud-based platform addressed the demand for process streamlining, bringing forecasting efficiencies.
Our comprehensive epidemiology database launch offered our clients a change in approach to data analysis, to spend less time manipulating data and more time thinking about the forecast.
We embraced the AI revolution, leading the integration of AI/ML tools into forecasting software to improve market sizing and peak share estimation and expand understanding of disease evolution.
Now, our comprehensive range of forecasting support services gives clients on-demand access to our consultancy team to expand their forecasting capabilities and enhance efficiency.
Evaluate, a Norstella company, acquired J+D Forecasting, merging top-tier consensus forecasting, consulting, and specialized analytical solutions, enabling our customers to elevate their forecasting.